Tag: VAM
SVS responds to New York Times article on overuse of vascular...
In an official Society response, SVS president Joseph Mills tackles recent coverage in the mainstream media of inappropriateness in vascular care.
There have been several...
Researchers report higher three-year amputation and reintervention rates in Black and...
In a study of over 7,000 chronic limb-threatening ischaemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention...
INCRAFT device deemed safe and effective according to its five-year results
Five-year data from the INSPIRATION US investigational device exception (IDE) pivotal trial confirms favourable safety and effectiveness of the INCRAFT device. Presenting the trial...
SVS VQI data being “fortified” to shed light on long-term paclitaxel...
Kim Hodgson (Springfield, USA), president of the Society for Vascular Surgery (SVS) for 2019–20 spoke to Vascular News at the organisation’s Vascular Annual Meeting...
